Patent details

EP1480679 Title: PHARMACEUTICAL FORMULATION OF IRESSA COMPRISING A WATER-SOLUBLE CELLULOSE DERIVATIVE

Basic Information

Publication number:
EP1480679
PCT Application Number:
PCT/GB/2003/000803
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP037067329
PCT Publication Number:
WO/2003/072139
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATION OF IRESSA COMPRISING A WATER-SOLUBLE CELLULOSE DERIVATIVE
French Title of Invention:
FORMULATION PHARMACEUTIQUE D'IRESSA COMPRENANT UN DERIVE DE CELLULOSE SOLUBLE DANS L'EAU
German Title of Invention:
PHARMAZEUTISCHE IRESSA ZUSAMMENSETZUNG ENTHALTEND EIN WASSERLÖSLICHES CELLULOSEDERIVAT
SPC Number:

Dates

Filing date:
24/02/2003
Grant date:
23/05/2007
EP Publication Date:
23/05/2007
PCT Publication Date:
04/09/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/12/2004
EP B1 Publication Date:
23/05/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/02/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/02/2003
 
 

Name:
AstraZeneca AB
Address:
Sodertalje, 151 85, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
12/06/2007
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PARKER Michael Davis
Address:
United Kingdom (GB)

2

Name:
GELLERT Paul Richard
Address:
United Kingdom (GB)

3

Name:
DE MATAS Marcel
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0204392
Priority Date:
26/02/2002
Priority Country:
United Kingdom (GB)

2

Priority Number:
0212462
Priority Date:
30/05/2002
Priority Country:
United Kingdom (GB)

3

Priority Number:
0213267
Priority Date:
11/06/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 47/38;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/02/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages